Status:
COMPLETED
Quality Project to Evaluate and Validate the FAST-O Rating Scale
Lead Sponsor:
AstraZeneca
Conditions:
Acute Psychotic Symptoms
Eligibility:
All Genders
Brief Summary
The purpose of this project is to test the reliability of the FAST-O Rating Scale in patients at acute wards or psychiatric intensive care units.
Eligibility Criteria
Inclusion
- Patients with acute psychotic symptoms attending the acute ward or psychiatric intensive care unit
Exclusion
- Not applicable
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
111 Patients enrolled
Trial Details
Trial ID
NCT00913731
Start Date
May 1 2009
End Date
October 1 2009
Last Update
October 29 2009
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Helsingborg, Sweden
2
Research Site
Kristianstad, Sweden
3
Research Site
Lund, Sweden
4
Research Site
Malmo, Sweden